Technetium-99m-labeled ceftizoxime loaded long-circulating and pH-sensitive liposomes used to identify osteomyelitis

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4605-8. doi: 10.1016/j.bmcl.2012.05.105. Epub 2012 Jun 6.

Abstract

Osteomyelitis is an infectious disease located in the bone or bone marrow. Long-circulating and pH-sensitive liposomes containing a technetium-99m-labeled antibiotic, ceftizoxime, (SpHL-(99m)Tc-CF) were developed to identify osteomyelitis foci. Biodistribution studies and scintigraphic images of bone infection or non infection-bearing rats that had been treated with these liposomes were performed. A high accumulation in infectious foci and high values in the target-non target ratio could be observed. These results indicate the potential of SpHL-(99m)Tc-CF as a potential agent for the diagnosis of bone infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ceftizoxime / administration & dosage
  • Ceftizoxime / analogs & derivatives*
  • Ceftizoxime / chemistry
  • Ceftizoxime / pharmacokinetics
  • Ceftizoxime / therapeutic use
  • Disease Models, Animal
  • Hydrogen-Ion Concentration
  • Liposomes
  • Male
  • Molecular Structure
  • Organ Specificity
  • Organotechnetium Compounds / administration & dosage
  • Organotechnetium Compounds / chemistry
  • Organotechnetium Compounds / pharmacokinetics*
  • Organotechnetium Compounds / therapeutic use*
  • Osteomyelitis / drug therapy*
  • Rats
  • Rats, Wistar
  • Staphylococcus aureus / drug effects

Substances

  • Liposomes
  • Organotechnetium Compounds
  • technetium 99m ceftizoxime
  • Ceftizoxime